Log in to save to my catalogue

Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer

Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9791638

Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer

About this item

Full title

Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer

Publisher

New York: Springer US

Journal title

Current oncology reports, 2023-02, Vol.25 (2), p.83-91

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Purpose of Review
The treatment options for high-risk non-muscle invasive bladder cancer (NMIBC), particularly following BCG, remain limited. We highlight recent, promising therapies for high-risk NMIBC.
Recent Findings
Several therapies utilizing different mechanisms of action have demonstrated favorable results in the BCG-naïve and BCG-u...

Alternative Titles

Full title

Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9791638

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9791638

Other Identifiers

ISSN

1523-3790,1534-6269

E-ISSN

1534-6269

DOI

10.1007/s11912-022-01350-9

How to access this item